ArticleFrontiers in pharmacology2022
Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study.
Marco Ceccanti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it